CA Stock MarketDetailed Quotes
MDNA Medicenna Therapeutics Corp
- 1.900
- -0.040-2.06%
15min DelayMarket Closed Jul 19 16:00 ET
142.08MMarket Cap-8260P/E (TTM)
1.940High1.850Low47.30KVolume1.910Open1.940Pre Close89.55KTurnover2.98052wk High0.10%Turnover Ratio74.78MShares0.21552wk Low-0.23EPS TTM94.13MFloat Cap7.250Historical HighLossP/E (Static)49.54MShs Float0.215Historical Low-0.16EPS LYR4.64%Amplitude--Dividend TTM7.63P/B1Lot Size--Div YieldTTM
About Medicenna Therapeutics Corp Company
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
Company Profile
SymbolMDNA
Company NameMedicenna Therapeutics Corp
Founded2015
MarketTSE
Employees19
Fiscal Year Ends03-31
Address2 Bloor Street W. 7th Floor
CityToronto
CountryCAN
Zip CodeM4W 3E2
Websitehttps://www.medicenna.com
Company Executives
- Name
- Position
- Salary
- Dr. Fahar Merchant,PhD
- President, Chief Executive Officer and Chairman of the Board
- 877.19K
- Rosemina Merchant
- Chief Development Officer
- 613.71K
- David Hyman
- Chief Financial Officer and Corporate Secretary
- --
- Dr. Jack Geltosky
- Director
- --
- Karen A. Dawes, M.A.
- Independent Director
- 123.70K
- Dr. John H. Sampson, M.B.A.,M.D.,PhD
- Independent Director
- 111.83K
- Albert Beraldo, C.A.,C.P.A.
- Lead Independent Director
- 142.95K
Heat List
CA
Overall
Symbol
Latest Price
%Chg